Comments
The European Union’s top official said Thursday that two Covid-19 vaccines could receive conditional market authorisation as early as the second half of December.
Speaking after a meeting of EU leaders, European Commission president Ursula von der Leyen said the vaccines developed by Moderna and Pfizer, which created its serum with German drugmaker BioNTech, could be approved by the end of the year by the European Medicines Agency (EMA) if all proceeds now without any problem.
Also read: EU to buy up to 300 million doses of Pfizer-BioNTech vaccine
Von der Leyen added this is the very first step to be able to be on the market. Von der Leyen said the EMA is in constant contact with the FDA to synchronise the assessment of the vaccines.
Also read: ‘We can stop Covid-19’: Moderna vaccine success gives world more hope
The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States. Von der Leyen said earlier this week the commission hopes a deal with Moderna will be soon finalised.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.